VANNI, IRENE
VANNI, IRENE
100007 - Dipartimento di Medicina interna e specialità mediche
A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition
2014-01-01 Ugolotti, E.; Vanni, I.
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control
2017-01-01 Malnati, M. S.; Ugolotti, E.; Monti, M. C.; De Battista, D.; Vanni, I.; Bordo, D.; Sironi, F.; Larghero, P.; Di Marco, E.; Biswas, P.; Poli, G.; Vicenzi, E.; Riva, A.; Tarkowski, M.; Tambussi, G.; Nozza, S.; Tripodi, G.; Marras, F.; De Maria, A.; Pistorio, A.; Biassoni, R.
Afatinib for the treatment of non-small cell lung cancer
2015-01-01 Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F.
An improved method for HLA-B and -C supratyping
2015-01-01 Biassoni, R.; Malnati, M. S.; Vanni, I.; Raso, A.; Sironi, F.; Broccolo, F.; Garbarino, L.; Mazzocco, M.; Montera, M.; Larghero, P.; Di Marco, E.; Ugolotti, E.
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation
2012-01-01 Mascelli, S.; Raso, A.; Biassoni, R.; Severino, M.; Sak, K.; Joost, K.; Milanaccio, C.; Barra, S.; Grillo-Ruggieri, F.; Vanni, I.; Consales, A.; Cama, A.; Capra, V.; Nozza, P.; Garre, M. L.
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
2020-01-01 Ottonello, S.; Genova, C.; Cossu, I.; Fontana, V.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Tagliamento, M.; Alama, A.; Coco, S.; Boccardo, S.; Vanni, I.; Ferlazzo, G.; Moretta, L.; Grossi, F.; Mingari, M. C.; Carrega, P.; Pietra, G.
Belagenpumatucel-L for the treatment of non-small cell lung cancer
2015-01-01 Rijavec, Erika; Biello, Federica; Genova, Carlo; Barletta, Giulia; Maggioni, Claudia; Dal Bello, Maria Giovanna; Coco, Simona; Truini, Anna; Vanni, Irene; Alama, Angela; Beltramini, Sabrina; Grassi, Maria Attilia; Boccardo, Francesco; Grossi, Francesco
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
2017-01-01 Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F.
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study
2017-01-01 Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system
2014-01-01 Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F.
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
2022-01-01 Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin
2019-01-01 Mastracci, Luca; Gambella, Alessandro; Bragoni, Alberto; Pigozzi, Simona; Pastorino, Lorenza; Vanni, Irene; Tosi, Ilaria; Campora, Michela; Fiocca, Roberto; Grillo, Federica
Current State of Target Treatment in BRAF Mutated Melanoma
2020-01-01 Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F.
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients
2012-01-01 Benzi, F.; Vanni, I.; Cassina, G.; Ugolotti, E.; Di Marco, E.; Cirillo, C.; Cristina, E.; Morreale, G.; Melioli, G.; Malnati, M.; Biassoni, R.
Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines
2012-01-01 Vanni, I.; Ugolotti, E.; Raso, A.; Marco, E. D.; Melioli, G.; Biassoni, R.
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
2017-01-01 Truini, A.; Coco, S.; Nadal, E.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Biello, F.; Barletta, G.; Merlo, D. F.; Valentino, A.; Ferro, P.; Ravetti, G. L.; Stigliani, S.; Vigani, A.; Fedeli, F.; Beer, D. G.; Roncella, S.; Grossi, F.
Efficacy of motesanib diphosphate in non-small-cell lung cancer.
2014-01-01 Rijavec, E; Genova, C; Barletta, G; Biello, F; Dal Bello, Mg; Coco, S; Truini, A; Vanni, I; Alama, A; Boccardo, Francesco; Grossi, F.
Exosomes: a new horizon in lung cancer
2017-01-01 Vanni, I.; Alama, A.; Grossi, F.; Dal Bello, M. G.; Coco, S.
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
2021-01-01 Dalmasso, B; Pastorino, L; Nathan, V; Shah, N N; Palmer, J M; Howlie, M; Johansson, P A; Freedman, N D; Carter, B D; Beane-Freeman, L; Hicks, B; Molven, A; Helgadottir, H; Sankar, A; Tsao, H; Stratigos, A J; Helsing, P; Van Doorn, R; Gruis, N A; Visser, M; Wadt, K A W; Mann, G; Holland, E A; Nagore, E; Potrony, M; Puig, S; Menin, C; Peris, K; Fargnoli, M C; Calista, D; Soufir, N; Harland, M; Bishop, T; Kanetsky, P A; Elder, D E; Andreotti, V; Vanni, I; Bruno, W; Höiom, V; Tucker, M A; Yang, X R; Andresen, P A; Adams, D J; Landi, M T; Hayward, N K; Goldstein, A M; Ghiorzo, P
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome
2024-01-01 Andreotti, Virginia; Vanni, Irene; Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition | 1-gen-2014 | Ugolotti, E.; Vanni, I. | |
| Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control | 1-gen-2017 | Malnati, M. S.; Ugolotti, E.; Monti, M. C.; De Battista, D.; Vanni, I.; Bordo, D.; Sironi, F.; Larghero, P.; Di Marco, E.; Biswas, P.; Poli, G.; Vicenzi, E.; Riva, A.; Tarkowski, M.; Tambussi, G.; Nozza, S.; Tripodi, G.; Marras, F.; De Maria, A.; Pistorio, A.; Biassoni, R. | |
| Afatinib for the treatment of non-small cell lung cancer | 1-gen-2015 | Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F. | |
| An improved method for HLA-B and -C supratyping | 1-gen-2015 | Biassoni, R.; Malnati, M. S.; Vanni, I.; Raso, A.; Sironi, F.; Broccolo, F.; Garbarino, L.; Mazzocco, M.; Montera, M.; Larghero, P.; Di Marco, E.; Ugolotti, E. | |
| Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation | 1-gen-2012 | Mascelli, S.; Raso, A.; Biassoni, R.; Severino, M.; Sak, K.; Joost, K.; Milanaccio, C.; Barra, S.; Grillo-Ruggieri, F.; Vanni, I.; Consales, A.; Cama, A.; Capra, V.; Nozza, P.; Garre, M. L. | |
| Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer | 1-gen-2020 | Ottonello, S.; Genova, C.; Cossu, I.; Fontana, V.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Tagliamento, M.; Alama, A.; Coco, S.; Boccardo, S.; Vanni, I.; Ferlazzo, G.; Moretta, L.; Grossi, F.; Mingari, M. C.; Carrega, P.; Pietra, G. | |
| Belagenpumatucel-L for the treatment of non-small cell lung cancer | 1-gen-2015 | Rijavec, Erika; Biello, Federica; Genova, Carlo; Barletta, Giulia; Maggioni, Claudia; Dal Bello, Maria Giovanna; Coco, Simona; Truini, Anna; Vanni, Irene; Alama, Angela; Beltramini, Sabrina; Grassi, Maria Attilia; Boccardo, Francesco; Grossi, Francesco | |
| Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy | 1-gen-2017 | Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F. | |
| Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study | 1-gen-2017 | Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco | |
| Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system | 1-gen-2014 | Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F. | |
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients | 1-gen-2022 | Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza | |
| Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin | 1-gen-2019 | Mastracci, Luca; Gambella, Alessandro; Bragoni, Alberto; Pigozzi, Simona; Pastorino, Lorenza; Vanni, Irene; Tosi, Ilaria; Campora, Michela; Fiocca, Roberto; Grillo, Federica | |
| Current State of Target Treatment in BRAF Mutated Melanoma | 1-gen-2020 | Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F. | |
| Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients | 1-gen-2012 | Benzi, F.; Vanni, I.; Cassina, G.; Ugolotti, E.; Di Marco, E.; Cirillo, C.; Cristina, E.; Morreale, G.; Melioli, G.; Malnati, M.; Biassoni, R. | |
| Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines | 1-gen-2012 | Vanni, I.; Ugolotti, E.; Raso, A.; Marco, E. D.; Melioli, G.; Biassoni, R. | |
| Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma | 1-gen-2017 | Truini, A.; Coco, S.; Nadal, E.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Biello, F.; Barletta, G.; Merlo, D. F.; Valentino, A.; Ferro, P.; Ravetti, G. L.; Stigliani, S.; Vigani, A.; Fedeli, F.; Beer, D. G.; Roncella, S.; Grossi, F. | |
| Efficacy of motesanib diphosphate in non-small-cell lung cancer. | 1-gen-2014 | Rijavec, E; Genova, C; Barletta, G; Biello, F; Dal Bello, Mg; Coco, S; Truini, A; Vanni, I; Alama, A; Boccardo, Francesco; Grossi, F. | |
| Exosomes: a new horizon in lung cancer | 1-gen-2017 | Vanni, I.; Alama, A.; Grossi, F.; Dal Bello, M. G.; Coco, S. | |
| Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia | 1-gen-2021 | Dalmasso, B; Pastorino, L; Nathan, V; Shah, N N; Palmer, J M; Howlie, M; Johansson, P A; Freedman, N D; Carter, B D; Beane-Freeman, L; Hicks, B; Molven, A; Helgadottir, H; Sankar, A; Tsao, H; Stratigos, A J; Helsing, P; Van Doorn, R; Gruis, N A; Visser, M; Wadt, K A W; Mann, G; Holland, E A; Nagore, E; Potrony, M; Puig, S; Menin, C; Peris, K; Fargnoli, M C; Calista, D; Soufir, N; Harland, M; Bishop, T; Kanetsky, P A; Elder, D E; Andreotti, V; Vanni, I; Bruno, W; Höiom, V; Tucker, M A; Yang, X R; Andresen, P A; Adams, D J; Landi, M T; Hayward, N K; Goldstein, A M; Ghiorzo, P | |
| Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome | 1-gen-2024 | Andreotti, Virginia; Vanni, Irene; Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William |